发明名称 |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HCV INFECTIONS |
摘要 |
The present invention relates to uses, methods and compositions for treating an infection by a member of the Flaviviridae family, such as HCV, in a subject in need thereof. More particularly, the prevention invention relates to an agent effective to inhibit the binding of a HCV envelope glycoprotein (E1 or E2) to CD229 protein present on the surface of hepatocytes o an inhibitor of CD229 gene expression for use in the treatment of an HCV infection or for use in the treatment of a disease associated with an HCV infection in a subject in need thereof, such as acute or chronic hepatitis C or for use to prevent a subject from contracting HCV or for use in the prevention of liver diseases, such as liver fibrosis, liver cirrhosis or hepatocellular carcinoma. |
申请公布号 |
WO2012107589(A1) |
申请公布日期 |
2012.08.16 |
申请号 |
WO2012EP52398 |
申请日期 |
2012.02.13 |
申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE DE PICARDIE JULES VERNE;CENTRE HOSPITALIER UNIVERSITAIRE D'AMIENS;BOUHLAL, HICHAM;OSSART, CHRISTELE;CARTIER, FLORA |
发明人 |
BOUHLAL, HICHAM;OSSART, CHRISTELE;CARTIER, FLORA |
分类号 |
C07K16/28;A61P31/14;A61P35/00;C12N15/113 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|